Min Hao, Wenhan Wang, Anil Kumar, Wan Hairul Anuar Kamaruddin, Syafiqah Saidin, Nik Ahmad Nizam Nik Malek, Jerome Claverie, Hong Liu
The low survival rate and poor differentiation efficiency of stem cells, as well as the insufficient integration of implanted stem cells, limit the regeneration of bone defects. Here, we have developed magnetic ferroferric oxide-hydroxyapatite-polydopamine (Fe3O4-HAp-PDA) nanobelts to assemble mesenchymal stem cells (MSCs) into a three-dimensional hybrid spheroid for patterning bone tissue. These nanobelts, which are featured by their high-aspect ratio and contain Fe3O4 nanospheres with a PDA coating, can be manipulated by a magnetic field and foster enhanced cell-nanobelt interactions. This strategy has been demonstrated to be effective for both bone marrow mesenchymal stem cells and adipose-derived mesenchymal stem cells, enabling remote manipulation of stem cell spheroids and efficient spheroid fusion, which in turn accelerates osteogenic differentiation. Consequently, this methodology serves as an efficient and general tool for bone tissue printing and can potentially overcome the low survival rate and poor differentiation efficiency of stem cells, as well as mismatched interface fusion issues.
{"title":"Magnetic hydroxyapatite nanobelt-stem cell hybrid spheroids for remotely patterning bone tissues","authors":"Min Hao, Wenhan Wang, Anil Kumar, Wan Hairul Anuar Kamaruddin, Syafiqah Saidin, Nik Ahmad Nizam Nik Malek, Jerome Claverie, Hong Liu","doi":"10.1002/bmm2.12059","DOIUrl":"10.1002/bmm2.12059","url":null,"abstract":"<p>The low survival rate and poor differentiation efficiency of stem cells, as well as the insufficient integration of implanted stem cells, limit the regeneration of bone defects. Here, we have developed magnetic ferroferric oxide-hydroxyapatite-polydopamine (Fe<sub>3</sub>O<sub>4</sub>-HAp-PDA) nanobelts to assemble mesenchymal stem cells (MSCs) into a three-dimensional hybrid spheroid for patterning bone tissue. These nanobelts, which are featured by their high-aspect ratio and contain Fe<sub>3</sub>O<sub>4</sub> nanospheres with a PDA coating, can be manipulated by a magnetic field and foster enhanced cell-nanobelt interactions. This strategy has been demonstrated to be effective for both bone marrow mesenchymal stem cells and adipose-derived mesenchymal stem cells, enabling remote manipulation of stem cell spheroids and efficient spheroid fusion, which in turn accelerates osteogenic differentiation. Consequently, this methodology serves as an efficient and general tool for bone tissue printing and can potentially overcome the low survival rate and poor differentiation efficiency of stem cells, as well as mismatched interface fusion issues.</p>","PeriodicalId":100191,"journal":{"name":"BMEMat","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12059","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138586852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this article number 10.1002/bmm2.12055, Fuhang Jiao, Wei Zhao and their co-workers developed a biomass-derived wound dressing exploiting the composite of water-soluble fish gelatin (FG) and antibacterial ZnO@silk fibroin (ZSF) microspheres. The ZSF microspheres serve as both germicide and hydrophile components, endowing the composite with excellent antimicrobial capacity and water solubility. The ZSF/FG composite can be easily removed from the wound using excess water, thereby preventing secondary damage. Additionally, the full-thickness skin wound model on infected mice demonstrated efficient wound closure and reduced inflammatory response. The ZSF/FG composite is expected a promising candidate as wound dressing for clinical therapy.